Maria Luszczyn: Does Blood Transfusion Really Worsen Long-Term Survival after CABG or is Preoperative Anemia the Main Driver?
Maria Luszczyn, Clinical Coordinator at Medinet – Lower Silesian Heart Center, shared a post on LinkedIn:
“Does blood transfusion really worsen long-term survival after CABG or is preoperative anemia the main driver?
In our latest study from the Zbigniew Religa Heart Center in Nowa Sól we evaluated 1,458 consecutive patients undergoing isolated CABG with a median follow-up of 5.4 years.
Using propensity score matching, we analyzed the two factors separately:
- Preoperative anemia (mostly mild) was significantly associated with decreased long-term survival (HR: 1.56, p=0.029).
- Perioperative PRBC transfusion, after balancing baseline and operative risks, did not adversely affect late survival (HR: 0.92, p=0.70).
These findings align with the principles of Patient Blood Management (PBM), supporting that proactive, early correction of anemia before surgery should remain a key clinical priority rather than relying on blood products later on.
Grateful to the entire team and my co-authors for collaborating on this project!”
Title: Association of preoperative anemia and blood transfusion with long-term survival after coronary artery bypass grafting
Authors: Maria Łuszczyn, Łukasz Moskal, Ryszard Stanislawski, Maciej Peksa, Marcin Nawotka, Siarhei Amelchanka, Tomasz Stankowski, Mirosław Brykczyński, Romuald Cichon, Sleiman Sebastian Aboul-Hassan
Stay updated with Hemostasis Today.
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers